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OBJECTIVEdYouth with diabetes are at increased risk for depression. The objectives of this
study were to provide preliminary evidence that this at-risk status for depression is associated
with metabolic and inﬂammatory markers and to inform future, more stringent examinations of
the directionality of these associations.
RESEARCH DESIGN AND METHODSdData from SEARCH for Diabetes in Youth
(SEARCH), an observational study of U.S. children diagnosed with diabetes at ,20 years of
age, were used for these analyses. SEARCH participants were drawn from four geographically
deﬁned populations in Ohio, Washington, South Carolina, and Colorado; health plan enrollees
in Hawaii and California; and Indian Health Service beneﬁciaries from four Native American
populations. Participants were 2,359 youth with diabetes from the 2001 prevalent and 2002–
2004 incident SEARCH cohorts. Depression was measured with the Center for Epidemiologic
Studies Depression scale. Eight metabolic and inﬂammatory markers were measured: adiponectin,
leptin, C-reactive protein, serum amyloid A, apolipoprotein B (apoB), lipoprotein A, interleukin-
6, and LDL.
RESULTSdSix of eight markers were signiﬁcantly (P, 0.006) associated with depression in
youth with diabetes in bivariate analyses. In general, higher levels of depression were associated
with indicators of worse metabolic or inﬂammatory functioning. In regression models stratiﬁed
by diabetes type and accounting for demographic and clinical characteristics, only higher levels
of apoB remained associated with higher levels of depression in youth with type 1 diabetes.
CONCLUSIONSdThese data suggest that depression reported by youth with diabetes is
partially associated with metabolic abnormalities and systemic inﬂammation.
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Depression is a common comorbidcondition in individuals with type 1or type 2 diabetes (1). Depression is
linked to poorer diabetes management
and control in both children and adults
(2,3). Much of this increased risk for
depression and associated morbidities is
attributed to the lifestyle aspects of dis-
ease management and the burden of
managing a chronic condition. Although
recent reports suggest the possibility of
biological links to depression in adults
with diabetes, such as lipid abnormalities
and systemic inﬂammation (4), studies
have not examined metabolic and inﬂam-
matory factors as biological correlates of
depression in youth with diabetes. Given
the studies implicating immune system
activity in both diabetes and depression
(5–7) and the absence of data on corre-
lates and directional pathways, this anal-
ysis was undertaken to evaluate the
potential for a biological link between de-
pression and metabolic and inﬂammatory
markers. We hypothesized that higher
levels of depressive symptoms would be
associated with metabolic abnormalities
and systemic inﬂammation in youth with
diabetes. To test this,we conducted a cross-
sectional investigation of these potential
associations in the SEARCH for Diabetes
in Youth (SEARCH) cohort.
RESEARCH DESIGN AND
METHODSdSEARCH is an observa-
tional study of youth in the United States
with diabetes diagnosed before the age of
20 years. SEARCH participants are drawn
from four geographically deﬁned popu-
lations in Ohio, Washington, South Car-
olina, and Colorado; health plan enrollees
in Hawaii and California; and Indian
Health Service beneﬁciaries from four
Native American populations. SEARCH
participants were eligible for inclusion in
this analysis if they were part of the 2001
(prevalent) or 2002–2004 (incident) co-
horts and completed the study visit.
At the study visit, demographic, di-
abetes, depression, and laboratory data
were collected. Depression was mea-
sured with the Center for Epidemiologic
Studies Depression (CES-D) scale; a 20-
item, questionnaire that is widely used
and has been adapted for use with chil-
dren and adolescents (8). Higher scores
indicate more depressive symptoms. An-
thropometric measurements (height and
weight) were obtained to calculate BMI.
A fasting venipuncture was performed
in each participant as part of a separate
SEARCH study aim to investigate meta-
bolic and inﬂammatory markers associ-
ated with type of diabetes and insulin
resistance. As part of this protocol, the
following analytes were measured: adipo-
nectin, leptin, C-reactive protein (CRP),
serum amyloid A (SAA), apolipoprotein
B (apoB), lipoprotein A (LPA), interleu-
kin-6 (IL-6), and LDL. Hemoglobin A1c
was also obtained via this fasting veni-
puncture. The eight markers have been
examined as indicators of metabolic
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abnormalities and systemic inﬂammation
in adults with depression.
To test the hypothesis that depression
was positively associated with metabolic
and inﬂammatory marker levels, CES-D
scores were grouped into no or minimal
depression (score of 0–15), mild depres-
sion (score of 16–23), and moderate or
severe depression ($24). These catego-
ries correspond to cutoffs in large, na-
tional samples of adolescents (9) that
distinguish depressive symptoms in
terms of their severity and likelihood
of later recurrence. In addition, these
categories have been used previously
in SEARCH publications (10). Analysis
of variance was conducted with the
Kruskal-Wallis correction for nonnormal
distributions to test marker levels be-
tween depression categories (i.e., does
the level of apoB vary signiﬁcantly by
depression level?). This was done in the
full sample and by diabetes type. P ,
0.006 was set to indicate statistical signif-
icance given multiple bivariate tests (i.e.,
Bonferroni correction).
Next, to test the relationships of the
markers with depression categories while
considering demographic and clinical
characteristics, regression models in the
general linear model framework were run
with each marker as a separate outcome,
stratiﬁed by diabetes type. Six of the
markers (CRP, SAA, apoB, leptin, LPA,
and IL-6) were log transformed to address
nonnormal distributions in marker levels.
Demographic and clinical covariates in-
cluded in each model were participant
age at study visit, sex, race or ethnicity,
highest parental education, health insur-
ance coverage (no insurance, private in-
surance, or public insurance), number of
caregivers in the home, duration of di-
abetes, BMI, and hemoglobin A1C. Note
that analyses were not conducted for the
small sample (n = 19) of youth with
“other” types of diabetes. All analyses
were completed with SAS software (ver-
sion 9.2).
RESULTSdThe mean age of the 2,359
participants included in this analysis was
15.26 3.1 years and the sample was 53%
female, 68% non-Hispanic white, and
85% had type 1 diabetes (Table 1). In
total, 22% of the participants were found
to have mild to moderate or severe de-
pressive symptoms by virtue of exceed-
ing established cutoffs for the CES-D
scale. With regard to the eight inﬂamma-
tory and metabolic markers, the means
and SDs are displayed by diabetes type
and depression category in Table 2. In
the full sample, there were signiﬁcant dif-
ferences (P, 0.006) between depression
categories for six of eight markers.
Adiponectin, leptin, CRP, SAA, apoB,
and LDL levels differed by depression
category. With the exception of SAA, all
were in the expected direction (i.e., a
higher depression category was associ-
ated with greater metabolic abnormali-
ties or systemic inﬂammation). For
participants with type 1 diabetes, CRP
and apoB differed signiﬁcantly by depres-
sion category (P , 0.006; leptin, P =
0.037; SAA, P = 0.052; LDL, P = 0.054).
In the subsample of participants with
type 2 diabetes, no markers differed sig-
niﬁcantly by depression category (all P.
0.10).
After adjustment for demographic
and clinical covariates and stratiﬁcation
by diabetes type, all regression models
were statistically signiﬁcant; however,
only the apoB model for participants
with type 1 diabetes included depression
category as a signiﬁcant correlate (F[20,
1961] = 26.88; P, 0.0001; R2 = 0.22. No
markers were signiﬁcantly associated with
depression among participants with type 2
diabetes. Among youth with type 1 diabe-
tes, those with moderate or severe depres-
sion scores (CES-D score $24) had apoB
levels at 80.9 mg/dL, in contrast to those in
themild depression category (mean of 75.4
mg/dL) and the no or minimal depression
category (mean of 75.5 mg/dL).
CONCLUSIONSdThe results pro-
vide preliminary evidence that higher
levels of depression are associated with
metabolic abnormalities and systemic in-
ﬂammation. The proportion of youth
with diabetes in this sample who reported
clinically signiﬁcant depressive symp-
toms (22%) is consistent with population-
based reports (9), suggesting that the
results may generalize to the larger pop-
ulation. Given the cross-sectional nature
of this investigation, however, it is not
possible to delineate speciﬁc contribu-
tions to depression of these biological
disruptions versus diabetes, nor the
direction of these relationships. In addi-
tion, we cannot determine whether there
are mutually reinforcing relationships
among diabetes, depression, and back-
ground metabolic and inﬂammatory
markers, like those suggested in the liter-
ature (4,11). These data do, however,
shed light on potential pathways and
suggest that further, more stringent in-
quiry is warranted.
For example, after adjustment for de-
mographic and clinical characteristics,
the link between higher depression scores
Table 1dParticipant characteristics by diabetes type
Overall Type 1 Type 2
N 2,359 2,007 333
Age (years) 15.2 6 3.1 15.0 6 3.1 16.6 6 2.8
Female sex 1,243 (52.7) 1,025 (51.1) 209 (62.8)
Race or ethnicity
Non-Hispanic white 1,613 (68.4) 1,531 (76.3) 71 (21.3)
Hispanic 326 (13.8) 243 (12.1) 78 (23.4)
Black/African American 253 (10.7) 148 (7.4) 103 (30.9)
Asian or Paciﬁc Islander 99 (4.2) 63 (3.1) 35 (10.5)
Native American 57 (2.4) 14 (0.7) 43 (12.9)
Other or unknown 11 (0.5) 8 (0.4) 3 (0.9)
Diabetes duration (years) 4.8 6 4.2 5.2 6 4.3 2.4 6 2.0
Hemoglobin A1c (%) 8.4 6 1.9 8.4 6 1.7 8.1 6 2.6
BMI (z score) 0.82 6 0.97 0.65 6 0.87 1.87 6 0.80
Insurance
Private 1,828 (78.0) 1,640 (82.2) 176 (53.5)
State (Medicaid) 394 (16.8) 279 (14.0) 112 (34.0)
Other 61 (2.6) 37 (1.9) 22 (6.7)
None 61 (2.6) 40 (2.0) 19 (5.8)
CES-D category
No/minimal 1,832 (77.7) 1,617 (80.6) 202 (60.7)
Mild 328 (13.9) 257 (12.8) 69 (20.7)
Moderate/severe 199 (8.4) 133 (6.6) 62 (18.6)
Data are n (%) or means 6 SD, unless otherwise noted.
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and higher apoB levels (i.e., dyslipidemia)
remained for youth with type 1 diabetes.
Those youth in the highest depression
category had apoB values 6 mg/dL higher
than those with mild to minimal symp-
toms, and their values were signiﬁcantly
closer to the 100mg/dL level suggestive of
clinical elevation (12). Further, if in future
studies the elevation in apoB is conﬁrmed
to be attributable to depression, a new
modiﬁable target for intervention (13,14)
would be identiﬁed.
Recent evidence does point to the
immediate and long-term contributions
of apoB to both diabetes-related and car-
diovascular disease outcomes (15,16).
The presence and severity of cardiovascu-
lar disease have also been linked with
depression through environmental path-
ways (17,18). Type 1 diabetes thus may
be an underlying contributor to the ob-
served emotional and biological dis-
ruptions, with depression exacerbating
dyslipidemia (12). This may occur
through overlapping neuroendocrine
pathways or lifestyle behaviors related to
diet and physical activity. The fact that
apoB came out as the only metabolic
marker signiﬁcantly associated with de-
pression in the multivariate analyses sug-
gest that the relationship between apoB
and depression is less affected by medi-
ating inﬂuences such as glycemic con-
trol and BMI than other by metabolic
variables (e.g., LDL) and their relationship
with depression.
Similarly, a greater degree of depres-
sion was linked with CRP, a measure of
systemic inﬂammation, although this as-
sociation was no longer evident after
adjustment for clinical and demographic
factors. These data may indicate an active
immune system contributing to the pres-
ence of depression. This possibility is
supported by the association of circu-
lating proinﬂammatory cytokines with
higher levels of depressive symptoms
(5,19). Alternatively, the elevation of
CRP may be a result of systemic inﬂam-
mation resulting from diabetes only, as
suggested by a number of studies (7,20).
Nevertheless, the results of this study
suggest that further inquiry into the di-
rection and magnitude of the pathways
linking depression and diabetes, particu-
larly type 1 diabetes, in youth is warran-
ted. Potential bidirectional or cyclical
relationships, which have garnered sup-
port in adults (4), also appears worthy of
further inquiry. Future studies should
aim to investigate these relationships
over time, comparing youth in this study
with metabolically challenged youth
without diabetes to document the inﬂu-
ence of diabetes, to examine these rela-
tionships in a larger sample of youth
with type 2 diabetes, to control for other
potentially inﬂuential variables such as
early indicators of complications, to de-
termine the effects of lowering depression
on apoB (and vice versa), and to elucidate
the inﬂuences of clinical variables (BMI
and hemoglobin A1c) and environmental
factors (diet and exercise) on this relation-
ship over time.
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Table 2dMetabolic and inﬂammatory markers by diabetes type and CES-D category
Full sample
CES-D category
,16 (no/minimal) 16–23 (mild) $24 (moderate/severe)
Type 1 diabetes
Adiponectin (ng/mL) 17,264 6 6,802 17,173 6 6,691 17,868 6 7,370 17,211 6 6,985
Leptin (ng/dL) 8.3 6 9.2 8.3 6 9.2 8.9 6 8.6 10.5 6 10.8
CRP 0.20 6 0.53 0.19 6 0.54 0.18 6 0.34 0.32 6 0.67
SAA 0.72 6 2.41 0.73 6 2.58 0.59 6 1.17 0.88 6 2.10
ApoB 77.0 6 23.3 75.9 6 22.2 79.5 6 26.6 86.3 6 27.1
LPA (nmol/L) 55.3 6 72.5 53.0 6 69.1 66.0 6 84.7 63.2 6 84.8
IL-6 (pg/mL) 17.7 6 24.9 17.5 6 22.6 19.8 6 38.3 16.2 6 18.3
LDL 0.278 6 0.022 0.279 6 0.021 0.277 6 0.022 0.274 6 0.022
Type 2 diabetes
Adiponectin (ng/mL) 9,618 6 5,345 9,414 6 4,883 9,933 6 5,882 9,932 6 6,165
Leptin (ng/dL) 23.1 6 18.8 20.8 6 16.3 24.9 6 17.3 28.6 6 25.6
CRP 0.50 6 1.00 0.51 6 1.18 0.54 6 0.67 0.41 6 0.52
SAA 0.93 6 4.00 1.07 6 5.03 0.77 6 1.52 0.64 6 1.02
ApoB 96.0 6 43.2 93.6 6 42.8 98.7 6 31.3 100.6 6 54.6
LPA (nmol/L) 51.2 6 63.5 48.6 6 58.5 52.0 6 60.9 58.7 6 80.4
IL-6 (pg/mL) 15.5 6 26.2 14.1 6 19.9 19.8 6 40.6 15.5 6 23.8
LDL 0.253 6 0.033 0.254 6 0.035 0.254 6 0.027 0.248 6 0.036
Values are means 6 SD in milligrams per deciliter unless otherwise noted.
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